Statements (45)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:verapamil
|
| gptkbp:approves |
gptkb:1981
|
| gptkbp:brand |
gptkb:Verelan
Calan Covera-HS |
| gptkbp:category |
Category C
|
| gptkbp:class |
gptkb:television_channel
|
| gptkbp:clinical_trial |
hypertrophic cardiomyopathy
chronic stable angina supraventricular tachycardia vasospastic angina off-label use for atrial fibrillation off-label use for migraine prevention |
| gptkbp:contraindication |
cardiogenic shock
severe hypotension sick sinus syndrome |
| gptkbp:dosage_form |
varies by condition
240 to 480 mg daily |
| gptkbp:duration |
6 to 8 hours
|
| gptkbp:effective_date |
FDA approved
|
| gptkbp:excretion |
urine
|
| gptkbp:form |
gptkb:tablet
injection injection solution extended-release capsule sustained-release tablet |
| https://www.w3.org/2000/01/rdf-schema#label |
Isoptin
|
| gptkbp:ingredients |
gptkb:verapamil
|
| gptkbp:interacts_with |
gptkb:digoxin
antihypertensives beta-blockers |
| gptkbp:is_used_for |
gptkb:musician
hypertension |
| gptkbp:lifespan |
5 to 12 hours
|
| gptkbp:manager |
oral
intravenous |
| gptkbp:manufacturer |
various
|
| gptkbp:metabolism |
liver
|
| gptkbp:premiered_on |
1 to 2 hours
|
| gptkbp:side_effect |
dizziness
headache nausea constipation |